Cargando…
Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
Background: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke. We attempt to elucidate the risk factors for ISR. Methods: We r...
Autores principales: | Guo, Xu, Ma, Ning, Gao, Feng, Mo, Da-Peng, Luo, Gang, Miao, Zhong-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871004/ https://www.ncbi.nlm.nih.gov/pubmed/33574792 http://dx.doi.org/10.3389/fneur.2020.601199 |
Ejemplares similares
-
Corrigendum: Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
por: Guo, Xu, et al.
Publicado: (2021) -
Protocol for a prospective, multicentre registry study of stenting for symptomatic intracranial artery stenosis in China
por: Wang, Yilong, et al.
Publicado: (2014) -
Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
por: Si, Jiang-Hua, et al.
Publicado: (2022) -
Balloon Angioplasty vs. Stenting for Symptomatic Intracranial Arterial Stenosis
por: Sun, Yaxuan, et al.
Publicado: (2022) -
Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis
por: Wang, Ning, et al.
Publicado: (2023)